Co-author on research applying AI interpretability to Pleiades epigenetic foundation model for Alzheimer's detection from cell-free DNA.
How media typically covers Christoforos Nalmpantis
Referenced in coverage
Using interpretability methods on an AI model trained to detect Alzheimer's from blood samples, researchers identified DNA fragment length patterns (fragmentomics) as a novel biomarker class that generalizes better than previously reported biomarkers when tested on independent cohorts.
“Co-author on research applying AI interpretability to Pleiades epigenetic foundation model for Alzheimer's detection from cell-free DNA.”